EMA Lapsed: Fexeric (ferric citrate coordination complex) — Akebia Europe Limited

View source ↗

Summary

EMA has lapsed the marketing authorization for Fexeric (ferric citrate coordination complex) in Europe, with hyperphosphatemia and renal dialysis listed as ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia
• Renal Dialysis

Drugs mentioned

• Fexeric (ferric citrate coordination complex)

Snippet

Status: Lapsed. Therapeutic area: Hyperphosphatemia;Renal Dialysis. MAH: Akebia Europe Limited. Decision date: 09/09/2019